Clinical trial
A Remote, 9-week Insomnia Treatment Trial to Collect Real World Data for a…
NCT04325464 · Pear Therapeutics, Inc., Industry · Unknown status
Key facts
| NCT number | NCT04325464 |
|---|---|
| Title | A Remote, 9-week Insomnia Treatment Trial to Collect Real World Data for a Digital Therapeutic |
| Official title | Open-label, 9-week Treatment, De-centralized Trial to Collect Real World Evidence for a Digital Therapeutic (DT) Delivering Cognitive Behavioral Therapy for Insomnia (CBT-I) for Participants With Chronic Insomnia |
| Acronym | DREAM |
| Lead sponsor | Pear Therapeutics, Inc., Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Chronic Insomnia |
| Intervention type | Device |
| Interventions | PEAR-003A |
| Enrollment | 1,590 |
| Start date | Feb 18, 2020 |
| Primary completion | Oct 21, 2022 |
| Completion | Oct 31, 2024 |
| First posted | Mar 27, 2020 |
| Last update posted | Feb 1, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: